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Abstract
This prospective acute gastroenteritis (AGE) surveillance was conducted in the inpatient and 
emergency room settings at a referral pediatric hospital to determine the prevalence of 
diarrheagenic Escherichia coli (DEC) in children<12 years of age with AGE in Davidson County, 
Tennessee. Subjects 15 days to 11 years of age, who presented with diarrhea and/or vomiting, 
were enrolled. Stool specimens were processed for detection of DEC using multiplex polymerase 
chain reaction. From December 1, 2011, to June 30, 2012, a total of 79 (38%) out of 206 stool 
specimens from children with AGE tested positive for E. coli. A total of 12 (5.8%) out of 206 
stool specimens from children with AGE were positive for a DEC. Eight (67%) out of these 12 
were positive for enteropathogenic E. coli, and the remaining 4 were positive for 
enteroaggregative E. coli. DEC clinical isolates clustered with known E. coli enteropathogens 
according to multilocus sequencing typing.
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1. Introduction
The Centers for Disease Control and Prevention (CDC) estimates that 0.6 episodes of 
diarrhea per person occur every year in the United States (Jones et al., 2007). Rates are 
higher for children under the age of 5 years. CDC estimates that 1 in 6 Americans per year 
(or 48 million people) is infected by foodborne pathogens, resulting in 128,000 
hospitalizations and 3000 deaths (Scallan et al., 2011a, 2011b). Most acute gastroenteritis 
(AGE) episodes (90%) were caused by 31 enteric pathogens including viruses 59%, bacteria 
(39%), and parasites (2%). The leading causes of AGE were norovirus (58%), nontyphoidal 
Salmonella spp. (11%), Clostridium perfringens (11%), Campylobacter spp. (9%), and 
Staphylococcus aureus (Scallan et al., 2011b). The leading causes of hospitalization were 
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nontyphoidal Salmonella spp. (35%), norovirus (26%), Campylobacter spp. (15%), and 
Shiga toxin–producing Escherichia coli 0157, while the leading causes of death were 
nontyphoidal Salmonella spp. (28%), norovirus (11%), and Campylobacter spp. (6%).
Shiga toxin–producing E. coli (STEC) are an important cause of foodborne illnesses in the 
United States, and the severity of the infection results in hospitalization and death. STEC are 
leading causes of dysenteric diarrhea and mortality secondary to hemolytic uremic syndrome 
(HUS) (Bavaro, 2012; Johnson et al., 2006; Rangel et al., 2005). Limited information is 
available on other E. coli intestinal pathotypes. Based on their mechanism of pathogenicity 
and unique arrays of virulence factors, the different pathotypes are designated 
enterotoxigenic (ETEC), enteropathogenic (EPEC), enteroaggregative (EAEC), 
enteroinvasive (EIEC), diffusely adherent (DAEC), and Shiga toxin–producing (STEC)/
enterohemorrhagic E. coli. Since diagnostic tools to differentiate these E. coli pathogens are 
typically not available at clinical laboratories or reference laboratory centers, little is known 
about their epidemiology.
We attempted to characterize and describe the epidemiology of E. coli pathogens in children 
who presented with AGE at a large, academic medical center in Nashville, Tennessee. We 
isolated E. coli strains from stools of children with diarrhea in a defined geographic area and 
tested them for genetic markers of known pathotypes of diarrheagenic E. coli (DEC).
2. Materials and methods
2.1. Study design and enrollment
This prospective, cross-sectional active surveillance study enrolled children who were 15 
days to 11 years old and who resided in Davidson County, Tennessee, presenting to the 
Vanderbilt Children's Hospital Emergency Department and inpatient units with diarrhea 
and/or vomiting from December 1, 2011, through June 30, 2012. AGE cases were enrolled if 
diarrhea, defined as ≥3 loose stools in a 24-hour period, or vomiting, ≥1 episode in a 24-
hour period, had occurred. Subjects were excluded for the following criteria: not residing in 
Davidson County, Tennessee, having symptoms at the time of presentation lasting ≥10 days 
in duration, immunocompromised, or an inability to understand English or Spanish. 
Demographic data, illness characteristics, medication, and travel history were obtained by 
chart review and standardized questionnaires. This study was approved by the Vanderbilt 
University Institutional Review Board (no. 120099).
2.2. Processing of stool specimens
Specimens consisted of at least 1 gram of whole stool in sterile containers or swabs of stool 
preserved in Cary–Blair transport media. Specimens plated on MacConkey agar (Becton 
Dickinson and Company, Sparks, MD, USA) and incubated overnight at 37 °C were 
examined for the presence of lactose-fermenting, nonmucoid colonies. Such isolates were 
subcultured onto eosin–methylene blue (EMB) agar (Remel, Lenexa, KS, USA) and 
incubated for 18–24 hours at 37 °C. Colonies with characteristic E. coli morphology on 
EMB agar (metallic green sheen) were inoculated into sulfide-indole-motility medium 
(Neogen Corporation, Lansing, MI, USA) for biochemical testing. Presumptive E. coli 
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isolates that were indole positive, motile, gas-producing, and negative for hydrogen sulfide 
production were confirmed as E. coli and stored at −80 °C for further testing as described 
before (Gómez-Duarte et al., 2010).
2.3. Preparation of DNA and DNA amplification by polymerase chain reaction (PCR) assays
Genomic DNA was isolated from E. coli clinical isolates by culturing strains in 2-mL Luria 
broth (LB) at 37 °C with shaking at 225 rpm overnight. A 200-μL aliquot of bacterial culture 
was centrifuged and pellet resuspended in 500 μL of Tris-EDTA buffer, boiled for 5 minutes 
and centrifuged at 10,000×g for 3 minutes. The supernatant containing crude genomic DNA 
was used as template for PCR. Two separate multiplex PCR reactions were performed on 
each DNA sample as described before (Gómez-Duarte et al., 2010). Mix 1 detected EPEC, 
EAEC, and STEC, and mix 2 detected ETEC, EIEC, and DAEC. Both mix 1 and mix 2 
reactions contained 18-μL PCR blue master mix (Invitrogen, Carlsbad, CA, USA), 1 μL of 
oligonucleotide mix 1 or oligonucleotide mix 2, and 1-μL DNA template. Reactions were 
preheated at 94 °C for 2 minutes and amplified for 40 cycles consisting of 30 seconds at 92 
°C, 30 seconds at 58 °C, and 30 seconds at 72 °C. PCR products were separated by 
electrophoresis using a 2% agarose gel containing ethidium bromide. Gel images were 
captured and analyzed.
2.4. Serotyping
O– and H– typing of DEC isolates was conducted at Pennsylvania State E. coli Reference 
Center (Pennsylvania State University, University Park, PA, USA). O– serotyping was 
conducted using antisera generated against E. coli serogroups designated O1-O187 with the 
exceptions of O31, O47, O67, O72, O94, and O122 as these are not designated. H– typing 
was performed by PCR–restriction fragment length polymorphism of fliC flagellar gene 
responsible for H types.
2.5. Antimicrobial susceptibility testing
Antimicrobial susceptibility to 12 different antibiotics was tested using BD BBL™ Sensi-
Disc™ Susceptibility Test Discs methods (Becton, Dickinson and Company Sparks, MD, 
USA). Strain activity was tested against cefazolin, ceftriaxone, ampicillin, amoxicillin/
clavulanic acid, ceftazidime, cefuroxime, cefepime, ciprofloxacin, gentamicin, meropenem, 
trimethoprim/sulfamethoxazole, and piperacillin/tazobactam (Qin et al., 2008). The zones of 
bacterial growth inhibition were interpreted according to the 2014 guidelines of the Clinical 
and Laboratory Standards Institute. Controls used for testing included the E. coli ATCC 
29522 as negative control (susceptible to all antibiotics) and Klebsiella pneumoniae ATCC 
700603D-5 as positive control (resistant to all beta-lactam antibiotics).
2.6. Biofilm formation assay
Biofilm quantitative assay was performed as described previously (Wakimoto et al., 2004). 
In brief, cultures were diluted in 297-μL Dulbecco's Modified Eagle Medium at a ratio of 
1:100 in a microcentrifuge tube and vortexed. One hundred microliters of the bacteria 
dilution was added to a 96-well plate, which was sealed with an adhesive film. The plate 
was then incubated at 37 °C for 24 hours. The plate was washed, and 125 μL of 0.1% crystal 
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violet solution was added to each well and incubated at room temperature for 15 minutes. 
The crystal violet was discarded and plate rewashed and air dried. Two hundred microliters 
of 95% ethanol was added to each well and incubated at room temperature for 15 minutes. 
The solubilized crystal violet was transferred to a 96-well Immulon 2 HB plate, and the 
optical density (OD) was measured at 590 nm. A strain was considered positive if the OD 
≥0.089.
2.7. Multilocus sequence typing (MLST)
E. coli clinical isolates were analyzed by MLST as described online (http://
mlst.warwick.ac.uk/mlst/). Internal fragments from 7 housekeeping genes, adk (adenylate 
kinase), fumC (fumarate hydratase), gyrB (DNA gyrase), icd (isocitrate/isopropylmalate 
dehydrogenase), mdh (malate dehydrogenase), purA (adenylosuccinate dehydrogenase), and 
recA (ATP/GTP binding motif of recombinase A), were amplified by PCR and DNA 
sequenced as described before (Wirth et al., 2006). Sanger DNA sequencing was conducted 
by the DNA core facility at Vanderbilt University. Forward and reverse DNA sequences for 
each gene and strain were aligned for comparison and editing. Sequence editing was 
conducted with DNADynamo software (Blue Tractor Software, North Wales, UK). 
Sequences for the 7 genes of each strain were concatenated to produce an alignment 
sequence of 3423 bp. Alignment of concatamers used ClustalW software available online at 
http://www.phylogeny.fr/version2_cgi/simple_phylogeny.cgi (Dereeper et al., 2008, 2010). 
Phylogenetic trees for all E. coli isolate and E. coli control MLST concatamers were 
conducted by bootstrapping procedure. E. coli control MLSTs included STEC, EPEC and 
ETEC strains reported in the http://mlst.warwick.ac.uk/mlst/ database and previously 
isolated from human cases of diarrhea. Control E. coli ancestral phylogenetic groups 
sequences were also obtained from the same database, including the E. coli Reference 
(ECOR) collection (Ochman and Selander, 1984). MLST-based clonal groups were defined 
as 2 or more E. coli strains with identical MLST sequence.
2.8. Statistical analysis
Data were analyzed using descriptive statistics, and epidemiologic variable distributions 
were identified. Central tendency and dispersion values were calculated for all variables 
analyzed using STATA version 12.
3. Results
3.1. Demographic characteristics of children with diarrhea
During the study period, 410 subjects were enrolled with AGE, and 299 of them consented 
for further E. coli testing. From the 299 subjects enrolled, 206 (69%) provided stool 
specimens for further analysis (Table 1). Eighty percent of these subjects (165 of 206) were 
<5 years old, and 54% were <1 year old, and gender was similar (54% male, 46% female).
3.2. Diarrheagenic E. coli identified among children with diarrhea
E. coli isolates were recovered from 38% (79 of 206) of the AGE specimens. Five individual 
E. coli isolates were obtained from each stool specimen up. Six percent (12 of 206) of the 
AGE specimens were positive for DEC. In those specimens, a minimum of 1 out the 
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maximum of 5 E. coli isolates per stool specimen was positive. Of the 12 subjects positive 
for DEC, the distribution of pathotypes revealed EPEC (67%, n = 8) and EAEC (33%, n = 
4). No STEC, ETEC, EIEC, or DAEC were identified. The mean age of subjects was 36 
months (Table 2). The mean age of subjects positive for EPEC was 25 months (SD 38, range 
2–114). Most cases of EPEC (6/8, 75%) were in children less than 5 years of age. The mean 
age of subjects positive for EAEC was 16.6 months (SD 16, range 5–39). All EAEC cases 
(4/4, 100%) were found in children less than 5 years of age (Table 2). None of the study 
subjects was found to have coinfections with multiple DEC. The majority of DEC were 
isolated from cases occurring during summer months.
3.3. Phenotypic and genotypic features of DEC strains
DEC isolates were characterized at the genetic and phenotypic levels. All EPEC strains (8 of 
8) were positive for the eae gene and negative for the bfpA gene indicating that they were 
atypical EPEC (aEPEC). Diverse numbers of serotypes were associated with EPEC strains, 
which included 4 O groups and 5 H groups. The majority of EPEC strains, 62% (5 of 8), 
were resistant to ampicillin (Table 3). All EAEC clinical isolates were positive for aggR and 
for aaiC. Three different O and H groups were recognized in the 4 EAEC clinical isolates. 
Only 2 strains had an identical serotype. All EAEC were resistant to ampicillin.
3.4. Few EAEC clinical isolates form biofilm of inert surfaces
EAEC strains typically form biofilms over inert and biological surfaces. To evaluate if 
EAEC clinical isolates form biofilms, individual colonies from cases with AGE were tested 
in a biofilm assay. Only 2 EAEC isolates from a single subject (ENIE-0245) were positive 
for biofilm formation (Fig. 1). The remaining EAEC isolates from the same subject and 
from the remaining 3 subjects with AGE were negative for biofilm formation. Control 
strains of E. coli produced the expected patterns: K12 and EAEC O42 were negative and 
positive, respectively, for biofilm formation.
3.5. Phylogenetic analysis
MLST conducted on E. coli pathotypes from subjects with AGE in Davidson County, 
Tennessee, revealed that they are genetically related to EPEC and EAEC clinical isolates 
previously reported in the MLST database (http://mlst.warwick.ac.uk/mlst/). MLST 
sequences from EPEC and EAEC isolates from children with AGE in Davidson County, 
Tennessee, were compared to similar sequences from EPEC clinical isolates from subjects 
with AGE and available in the MLST database (http://mlst.warwick.ac.uk/mlst/). We 
identified 5 previously reported MLST sequence types and 2 novel sequence types, among 
DEC isolates (Table 3). The 2 new sequence types ST4599 and ST4600, submitted to the 
MLST database, corresponded to the EAEC EN1I-0245 and EPEC EN1I-0027 strains 
(Table 3). The EPEC EN1I-027 MLST also had a new icd sequence designated icd486 that 
was also submitted to the MLST database. A phylogenetic tree constructed based on cluster 
W alignments of MLST concatemer sequences from Davidson County was compared with 
MLST sequences from ancestral E. coli strains from groups A, B1, B2, and D. As shown in 
Fig. 2, most DEC from Davidson County clustered with E. coli ancestral group A and B1 
strains. The only exceptions were the EPEC EN1I-0034 strain that clustered with ancestral 
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group B2 and the EPEC EN1I-0027 strain that was not related to any of the E. coli ancestral 
group strains.
EPEC isolates from Davidson County revealed close relationships with previously reported 
EPEC clinical isolates derived from AGE cases from different worldwide locations. EPEC 
EN1E-0139 strain with MLST sequence type 342 has a clonal relationship with EPEC 
Trh37, a Norway strain O177 isolated from a case of diarrhea (Fig. 3). EPEC strains 
EN1E-0224, EN1E-0241, and EN1I-0032 are also identical and cluster with E. coli ancestral 
group A and specifically with MLST sequence type 10 (ST10), associated with EPEC 
human pathogens. The remaining EPEC MLSTs we identified are not identical to EPEC 
from the MLST database, yet they are related (Fig. 3). The EPEC EN1I-0027 strain, for 
instance, is distantly related to EPEC 109 in the database, a Chinese O15 isolate from a case 
of diarrhea.
The 4 EAEC clinical isolates clustered with EAEC clinical isolates reported in the MLST 
database (Fig. 4). Two EAEC study strains formed a clonal group, in addition to identical 
MLST, and they also share identical O86:H27 serotype. Interestingly, the EAEC 
EN1E-0191 strain clustered also with ancestral group A, ST10, which is associated with 
both EPEC and EAEC strains. The EAEC EN1E-0245 strain is closely related to ST10, 
although it belongs to its own new sequence type ST4599 (Table 3).
4. Discussion
Diarrheagenic E. coli are a common cause of infant diarrhea in developing countries, but 
their impact in pediatric infectious diarrhea in industrialized nations remains unclear 
(Kotloff et al., 2013). Previous studies in the United States examining the prevalence of 
DEC have reported several E. coli pathotypes including STEC; EPEC; EAEC; and, less 
frequently, ETEC (Devasia et al., 2006; Denno et al., 2012; Klein et al., 2006; Nataro et al., 
2006). Our study identified atypical EPEC and EAEC as the 2 DEC pathotypes represented 
among patients with AGE in this geographic area. In our cohort, other E. coli pathotypes, 
including STEC strains which can cause HUS complications and mortality (Tarr et al., 
2005), were not found.
EPEC has been considered a cause of human disease since the 1940s (Walker-Smith, 1996). 
The identification of certain genetic determinants,eae (encodes intimin, which mediates 
aggregation) and bfpA (encodes the bundle-forming pilus), has aided in understanding EPEC 
pathogenicity (Jerse et al., 1990). aEPEC is defined as the presence of eae without bfpA 
(Trabulsi et al., 2002), and this represented the majority of our samples. While the 
pathogenic potential of aEPEC strains has been speculative in the past, a recent publication 
by the Global Enteric Multicenter Study (GEMS) showed aEPEC as the 5th most frequently 
detected pathogen in patients aged 0–11 months who died of AGE (Kotloff et al., 2013). The 
3.8% EPEC prevalence in this study is similar to that reported in other US geographic 
regions (Denno et al., 2012; Nataro et al., 2006; Caeiro et al., 1999). Additionally, typical 
EPECs (eae+, bfpA+) were found most frequently in that age group. Our EPEC-positive 
specimens were too few to demonstrate any association with age, which has been shown 
previously (Sakkejha et al., 2013). Interestingly, studies conducted in England and Peru 
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have shown that aEPEC is often found in children with and without diarrhea, whether in the 
developed or developing world (Hernandes et al., 2009; Ochoa and Contreras, 2011). 
Further surveillance studies in the United States that include healthy controls may provide 
clues on host risk factors as well as EPEC virulence factors that are associated with disease.
Of the 8 positive EPEC specimens, 2 (25%) had O119 serogroups consistent with 
recognized classic human EPEC serogrups (Levine and Edelman, 1984). One EPEC sample 
had an O serogroup bovine association (EPEC O35) (Blanco et al., 2005). Three EPEC 
isolates were nontypeable, and 2 belonged to O serogroups (O6, O108) not previously 
associated with EPEC strains. This may indicate that emergence of new O serogroups 
among EPEC strains in humans is associated with disease or with permanent or transient 
colonization of the human intestine without evidence of disease.
Studies from multiple cities in the United States, as well as cities in Brazil, Peru, and 
Burkina Faso, have repeatedly demonstrated that EAEC is the most frequently identified 
DEC found when specimens are tested for the 6 known pathotypes (Klein et al., 2006; 
Nataro et al., 2006; Bonkoungou et al., 2013; Cohen et al., 2005; Lozer et al., 2013). The 
1.9% EAEC prevalence in this study was lower than the one reported in the United States 
previously (Denno et al., 2012; Nataro et al., 2006). EAEC is typically defined by a 
“stacked-brick” aggregation pattern on HEp-2 cells directly associated with biofilm 
formation (Kaper et al., 1997). Increasingly, PCR methods detecting aggR (a central 
regulator of virulence) are being used for identification. Reliable ways of determining 
whether EAEC causes disease are difficult, as it is also known to cause asymptomatic 
colonization (Nüesch-Inderbinen et al., 2013). EAEC-positive specimens in this study were 
observed in younger children, consistent with observations in the United States and 
developing countries (Kotloff et al., 2013; Klein et al., 2006; Nataro et al., 2006; 
Bonkoungou et al., 2013; Lozer et al., 2013). The 4 EAEC strains isolated in the current 
study belonged to 3 serogroups: 2 O86 and 1 each O3 and O92. These serogroups have 
previously been associated with EAEC diarrheal disease and shown to display aggregative 
adhesion and biofilm formation (Knutton et al., 1992). Interestingly, only 1 EAEC isolate 
from 1 subject was positive for biofilm formation compared with EAEC strain control. This 
may indicate that the remaining EAEC isolates unable to form biofilm may be 
nonpathogenic intestinal colonizers. Alternatively, they may form biofilm only under host 
intestinal conditions.
Overall, DEC isolates were susceptible to the antibiotics tested in our study, with the 
exception of resistance to ampicillin (5/12, 41.6%). Only 1 strain was resistant to at least 3 
classes of antimicrobials. In contrast, multidrug resistance was reported among DEC isolates 
in Iran, Kenia, Mexico, and South Korea (Al Jarousha et al., 2011; Harel et al., 1991; Sang 
et al., 2012; Unno et al., 2011).
MLST typing of strains reveled associations between E. coli clinical isolates from Davidson 
County, Tennessee, and E. coli ancestral groups A and B1 known to be associated with 
intestinal disease (Gómez-Duarte et al., 2010; Guerra et al., 2014). EPEC clinical isolates 
demonstrated close MLST relationships with previously reported EPEC strains. Three EPEC 
and 1 EAEC Davidson County strains belong to MLST ST10, which includes EPEC and 
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EAEC pathotypes and belongs to the ancestral E. coli group A. These phylogenetic findings 
are strong evidence that EPEC and EAEC isolates are true intestinal pathogens with genetic 
traits that may favor human intestinal colonization.
The primary limitation of this study is low overall recovery of E. coli from diarrheal 
samples. Specimens were sometimes plated up to 15 days after collection, reducing the 
efficiency of E. coli culture isolation. Our study lacked an analysis of healthy control 
specimens, so association between E. coli pathotypes and disease cannot be definitively 
ascertained. As new multipanel systems for DEC detection become available, more accurate 
epidemiological data on DEC in the United States will be reported (Buss et al., 2015).
In summary, we have reported for the first time the presence of EPEC and EAEC E. coli 
pathotypes among children with AGE in Davidson County, Tennessee. The EPEC strains, 
the most frequently identified, were atypical as they do not carry bundle-forming pilus 
genes. EAEC strains were positive for both aggR and aaiC genes, yet only a single EAEC-
positive specimen was able to form biofilm. All pathotypes identified were genetically 
related to EPEC and EAEC pathotypes previously isolated from human cases of AGE. The 
role of these pathotypes in the epidemiology of AGE in Tennessee and in the United States 
warrants further systematic investigation. Information about common MLST types, 
serotypes, reservoirs, and antimicrobial resistance in prevalent EPEC and EAEC will aid in 
development of strategies to prevent spread and outbreaks.
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Quantitative biofilm formation assay on EAEC isolates. Individual colonies for each case of 
diarrhea positive for EAEC were tested in the biofilm assay. E. coli K12 and DH5 strains are 
negative controls, and EAEC O42 is positive control for biofilm formation. The optical 
density is proportional to the amount of bacteria attached to the inert surfaces. Interrupted 
line is the threshold above which the strain is positive for biofilm formation. The threshold 
corresponds to the average of the negative controls plus 2 times the SD. In this assay, the 
threshold was set at an absorbance (A590 nm) of 0.43.
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MLST phylogenetic tree of E. coli intestinal pathotypes isolated from children with AGE. 
Phylogenetic tree was constructed after assembly and alignment of MLST DNA sequences 
from diarrheagenic E. coli isolates using ClustalW program. E. coli MLST sequences from 
ancestral groups A, B1, B2, and D available at the MLST database (http://
mlst.warwick.ac.uk/mlst/) were used as controls. Arrows represent clinical isolates from 
Davidson County, Tennessee; thin arrows indicate EPEC study strains, and bold arrows 
indicate EAEC study strains.
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MLST phylogenetic tree of EPEC isolates. Phylogenetic tree of the 8 EPEC MLST 
sequences were compared with MLST sequences from ancestral groups A, B1, B2, and D as 
well as EPEC sequences, available at the MLST database (http://mlst.warwick.ac.uk/mlst/). 
EPEC MLST controls included: EPEC HC68; EPEC DEC2A; EPEC 2348/69; EPEC HC10; 
EPEC HC15; EPEC Trh36; EPEC DEC6A; EPEC DEC12B; EPEC Trh37; EPEC 181; 
EPEC HC40; EPEC HC36; EPEC HC91; EPEC HC95; EPEC HC59; EPEC HC66; EPEC 
HC87; EPEC 109; EPEC 219. E. coli ancestral control strain sequences are derived from the 
ECOR collection and they include clonal group B1, Ecor26 and Ecor28; clonal group A, 
Ecor9 and Ecor10; clonal group B2, Ecor56 and Ecor60; and clonal group D, Ecor35 and 
Ecor36. Arrows represent EAEC clinical isolates from Davidson County, Tennessee.
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MLST phylogenetic tree of EAEC isolates. Phylogenetic tree constructed after assembly and 
alignment of MLST DNA sequences using the ClustalW program. EAEC MLST sequences 
from study isolates: EN1E-0007, EN1E-0182, EN1E-0191, and EN1E-0245. E. coli MLST 
sequences from ancestral groups A, B1, B2, and D as well as STEC sequences, available at 
the MLST database, were used as controls. E. coli ancestral control strain sequences are 
derived from the ECOR collection. EAEC MLST sequences from human cases of diarrhea 
included: EAEC 4356/96; EAEC 101-1; EAEC 13-03250; EAEC 100; EAEC 236; EAEC 
C08; 42; EAEC C04; EAEC IE-3627; EAEC 10-06632; EAEC 1634; EAEC 1759; EAEC 
1772-2; EAEC 1723; EAEC 108; EAEC 1711; and EAEC 219; 188. Arrows represent 
EAEC isolates from Davidson County, Tennessee.
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Table 1
Demographics of children with acute gastroenteritis.
Negative for E. coli Positive for E. coli Pathogenic E. coli
a Total
Sex
Male 70 (63%) 41 (37%) 9 (8%) 111
Female 57 (60%) 38 (40%) 3 (3%) 95
Age
    <1 year old 46 (65%) 25 (35%) 5 (7%) 71
    1 to <2 years old 20 (53%) 18 (47%) 2 (5%) 38
    2 to <5 years old 35 (62%) 21 (38%) 3 (5%) 56
    5 to <10 years old 24 (67%) 12 (33%) 2 (6%) 36
    ≥10 years 2 (40%) 3 (60%) 0 (40%) 5
Race
    White 56 (54%) 47 (46%) 10 (8%) 103
    Black 61(68%) 29 (32%) 2 (3%) 90
    Asian 4 (100%) 0 0 4
    Other 6 (67%) 3 (33%) 0 9
a
Pathogenic E. coli are a subgroup of E. coli isolates that tested positive by PCR for either EPEC or EAEC.
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Table 2
Demographic features of AGE cases positive for diarrheagenic E. coli, December 2011–June 2012.
Sample Subject Age (months) Sex Race
a Ethnicity Month of isolation E. coli pathotype
1 EN1E-0007 18 M W NH/NL December EAEC
2 EN1E-0139 22 M W NH/NL March EPEC
3 EN1E-0182 4 F W H/L April EAEC
4 EN1E-0191 39 M W H/L May EAEC
5 EN1I-0027 2 M W NH/NL May EPEC
6 EN1I-0032 27 F W H/L May EPEC
7 EN1E-0224 41 M W NH/NL June EPEC
8 EN1E-0227 10 M B NH/NL June EPEC
9 EN1E-0232 113 F W NH/NL June EPEC
10 EN1E-0241 65 M W H/L June EPEC
11 EN1E-0245 8 M B NH/NL June EAEC
12 EN1I-0034 4 M W NH/NL June EPEC
a
Race: W represents white and B represent black. Ethnicity: H/L represents Hispanic or Latino and NH/NL represents non-Hispanic or non-Latino.
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Table 3
Genotypic and phenotypic features of diarrheagenic E. coli isolates.
Sample Subject Pathotype Virulence genes Serotype Sequence type Antibiotic resistance
b
1 EN1E-0007 EAEC aggR, aaiC O86:H27 3570 A
2 EN1E-0139 EPEC eae O6:H1 342 None
3 EN1E-0182 EAEC aggR, aaiC O86:H27 3570 A
4 EN1E-0191 EAEC aggR, aaiC O3:H2 10 A
5 EN1E-0224 EPEC eae O–:H– 10 A
6 EN1E-0227 EPEC eae O119:H21 40 A, A/C
7 EN1E-0232 EPEC eae O108:H9 302 None
8 EN1E-0241 EPEC eae O–:H– 10 A, A/C
9 EN1E-0245 EAEC aggR, aaiC O92:H33
ST4599
a A, A/C, S
10 EN1I-0027 EPEC eae O119:H30
ST4600
a A
11 EN1I-0032 EPEC eae O35:H10 10 None
12 EN1I-0034 EPEC eae O–:H9 779 A, S
a
New MLST sequence type submitted to http://mlst.warwick.ac.uk/mlst/.
b
A = ampicillin; A/C = amoxicillin/clavulanic acid; S = sulfamethoxazole-trimethoprim.
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